Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
Arielle L. Heeke, Antoinette R. Tan
Topics & Concepts
MedicineAtezolizumabPembrolizumabTriple-negative breast cancerMetastatic breast cancerBreast cancerOncologyImmunotherapyInternal medicineClinical trialChemotherapyCancerCombination therapyCancer Immunotherapy and BiomarkersAdvanced Breast Cancer TherapiesPARP inhibition in cancer therapy